The Hale Family Research Center is critical in identifying novel experimental therapies and characterizing them using preclinical models, with the goal of bringing groundbreaking new agents into clinical trials that will benefit patients. This provides patients at the Pancreas and Biliary Tumor Center of Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) with access to the latest and most sophisticated therapies tailored to their tumors.
The Pancreas and Biliary Tumor Center combines world-class patient care with leading-edge research to provide highly effective, personalized treatment options for patients with pancreatic and biliary disease. Our team of providers uses the most advanced diagnostics and state-of-the-art science to understand each patient’s tumor at the molecular level. This uniquely collaborative and patient-centered approach ensures the most sophisticated and compassionate care possible for every patient who comes for diagnosis or treatment.
The Pancreas and Biliary Tumor Center’s renowned clinical team provides comprehensive multidisciplinary care across the full spectrum of cancer services, including:
- Advanced diagnostic procedures
- Evaluation of cystic lesions
- Pathologic and molecular testing of tumor specimens
- Complex surgical procedures
- Radiation therapy (including radiosurgery techniques)
- Leading-edge clinical trials
- Nutrition and palliative care consultations
- Genetic testing and counseling for families with a cancer history
Watch an 8-minute video in which Thomas E. Clancy, MD, FACS, Surgical Oncology, and Brian M. Wolpin, MD, Medical Oncology, explain the mission of the Pancreas and Biliary Tumor Center at DF/BWCC, the treatment approaches that are used, and the ongoing research that examines ways to diagnose and treat pancreatic and biliary cancer in the early stages.